Natural Capsules Limited has informed the Exchange about General Updates
NATCAPSUQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natural Capsules Limited informed the exchanges that its material subsidiary, Natural Biogenex Private Limited, has approved a rights issue of 11,11,200 equity shares of ₹10 each at par, aggregating to approximately ₹1.11 crore. The decision was taken at the subsidiary's board meeting held on September 30, 2025. The filing was made under Regulation 30(9) of SEBI (LODR) Regulations, 2015. The purpose of the fund raise and the recipient shareholders of the rights issue have not been disclosed in this intimation.
This is a small capital raise at the subsidiary level and is unlikely to have a material impact on the parent company's stock price. Investors may want to watch for further details on the use of proceeds and any impact on the subsidiary's shareholding structure.